Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2009
10/29/2009US20090269857 Instruments for detecting low-molecular weight substance
10/29/2009US20090269856 Methods and compositions for evaluating breast cancer prognosis
10/29/2009US20090269853 Trioxyethylene gold nanoclusters functionalized with a single dna
10/29/2009US20090269837 System for assessing the efficacy of stored red blood cells using microvascular networks
10/29/2009US20090269836 Apparatus and Method for Analysing a Biological Sample in Response to Microwave Radiation
10/29/2009US20090269791 Non-proteolytic method for the determination of analytes in keratinized structures
10/29/2009US20090269790 Using fibrinogen cleavage product profiles as evaluative tool in prediciting medical equipment associated thrombotic events
10/29/2009US20090269789 Antibodies for detecting microorganisms
10/29/2009US20090269788 Method for detecting microorganism
10/29/2009US20090269787 Monoclonal Antibody to CD166 and Method for Production Thereof
10/29/2009US20090269786 RHO1-Gamma Amino Butyric Acid C Receptor-Specific Antibodies
10/29/2009US20090269785 Crystal structure of monoacylglycerol lipase (mgll)
10/29/2009US20090269784 Protein engineering of monoacylglycerol lipase (mgll)
10/29/2009US20090269783 B7-H2 molecules, novel members of the B7 family and uses thereof
10/29/2009US20090269782 Diagnostic method for determining the susceptibility to delivery and reagent kit for use therefor
10/29/2009US20090269781 Single-Molecule-Format Probe And Utilization Thereof
10/29/2009US20090269780 Method for Creating a Standard for Multiple Analytes Found in a Starting Material of Biological Origin
10/29/2009US20090269779 Galectin-3 cleavage as a marker for matrix metalloproteinase activity in cancer
10/29/2009US20090269778 Biocompatible three dimensional matrix for the immobilization of biological substances
10/29/2009US20090269777 Immunoassays and kits for the detection of ngal
10/29/2009US20090269776 Magnetic Immunodiagnostic Method for the Demonstration of Antibody/Antigen Complexes especially of blood groups
10/29/2009US20090269773 Methods of determining the health status of an individual
10/29/2009US20090269767 Microfluidic chip devices and their use
10/29/2009US20090269765 Compositions And Methods For Detection Of Small Molecules Using Dyes Derivatized with Analyte Responsive Receptors in a Chemiluminescent Assay
10/29/2009US20090269752 Method for selecting nucleic acids that bond with high-affinity to a target
10/29/2009US20090269751 Dot1 histone methyltransferases as a target for identifying therapeutic agents for leukemia
10/29/2009US20090269739 Kit for detection of telomerase reverse transcriptase nucleic acids
10/29/2009US20090269735 Sample pretreatment solution for immunological test and method for using the same
10/29/2009US20090269366 T cell epitope peptides of 6b11 ovarian cancer anti-idiotypic antibody
10/29/2009US20090269363 Method for screening peptides for use in immunotherapy
10/29/2009US20090269360 Therapy
10/29/2009US20090269356 Complement Binding Aptamers and Anti-C5 Agents Useful in the Treatment of Ocular Disorders
10/29/2009US20090269350 drug screening; used to identify compounds that act as agonists and antagonists and modulate the expression of the novel PGP synthase
10/29/2009US20090269346 Compositions Comprising Receptor-Associated Protein (RAP) Variants Specific for LRP2 and Uses Thereof
10/29/2009US20090269345 CLN248 Antibody Compositions and Methods of Use
10/29/2009US20090269343 Dual Specific Immunotoxin for Brain Tumor Therapy
10/29/2009US20090269342 Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
10/29/2009US20090269334 Biomarkers for graft rejection
10/29/2009US20090269333 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
10/29/2009US20090269332 Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor
10/29/2009US20090269325 using non-anticoagulant sulfated polysaccharides (NASPs) e.g. pentosan polysulfate or heparins as procoagulants for treating bleeding disorder selected from a chronic or acute bleeding disorder, a congenital coagulation disorder caused by a blood factor deficiency, and an acquired coagulation disorder
10/29/2009US20090269323 Non-amphiphile-based water-in-water emulsion and uses thereof
10/29/2009US20090269285 Diagnostic And Therapeutic Epitope, And Transgenic Plant
10/29/2009US20090269282 Methods for treating, preventing and diagnosing procine ttv infection
10/29/2009US20090269244 Detection of biochemical interactions on a biosensor using tunable filters and tunable lasers
10/29/2009US20090268194 Blood analysis apparatus and setting method of measurement position in blood analysis apparatus
10/29/2009US20090267032 Hydrogen Gas Detecting Material and the Coating Method
10/29/2009US20090266290 Buoyant-capable beverage and food content-sensor
10/29/2009US20090266184 Method for Rapid Testing of the Quality of Cereals, Grits and Flours by Measuring the Aggregation of Gluten
10/29/2009US20090266182 Method and inspecting device for identifying test specimen and multifunctional test specimen
10/29/2009DE102008020905A1 Vorrichtung zum Überwachen von Weichwasser Device for monitoring of soft water
10/29/2009DE102008020765A1 Measuring arrangement for contactless determination of location-related physical characteristics within flow volume of e.g. air in medical field, has measuring devices measuring differently oriented measuring section within flow volume
10/29/2009DE102008019116A1 Sensor arrangement for use in internal combustion engine of motor vehicle, comprises sensor unit, which has sensor element for measuring concentration of gas component in gas mixture
10/29/2009DE102008008367A1 Method for determining blood sugar level of human from lacrimal fluid for e.g. child, involves converting lacrimal glucose level into blood sugar level of specific user to determine blood sugar level by application of userspecific formula
10/29/2009DE102008001322A1 Sample array analysis system for use in e.g. pharma research, has detector detecting luminescence radiation emitted by samples, and light conductor array arranged in front of sample plate for conducting light on samples
10/29/2009DE102008001307A1 Verfahren zur Ermittlung der Zündwilligkeit eines Kraftstoffs Method for determining the ignition of a fuel
10/29/2009DE102008001306A1 Verfahren zur Charakterisierung der Klopffestigkeit von Kraftstoffen Method for characterizing the antiknock gasoline
10/29/2009DE102006045620B4 Vorrichtung und Verfahren für Aufnahme, Transport und Ablage mikroskopischer Proben Apparatus and method for the uptake, transport and storage of microscopic samples
10/29/2009DE10154458B4 Peptide zur Analyse von Gluten in Lebensmitteln und anderen Substanzgemischen und deren Verwendung Peptides for analysis of gluten in foodstuffs and other mixtures of substances and their use
10/29/2009CA2728980A1 Electrochemical assay
10/29/2009CA2725442A1 An assay to detect a gynecological condition
10/29/2009CA2722424A1 Cytological methods for detecting cancer
10/29/2009CA2722416A1 Method for predicting risk of metastasis
10/29/2009CA2722409A1 Libraries of genetic packages comprising novel hc cdr1, cdr2, and cdr3 and novel lc cdr1, cdr2, and cdr3 designs
10/29/2009CA2722396A1 Methods and apparatus for segregation of particles
10/29/2009CA2722173A1 Methods of identifying anti-inflammatory compounds
10/29/2009CA2722026A1 Plasma membrane vesicles and methods of making and using same
10/29/2009CA2721941A1 Methods for measuring changes in optical properties of wound tissue and correlating near infrared absorption (fnir) and diffuse reflectance spectroscopy scattering (drs) with tissue neovascularization and collagen concentration to determine whether wound is healing
10/29/2009CA2721833A1 Prion epitopes and methods of use thereof
10/29/2009CA2721799A1 Integrated shear-vertical surface acoustic wave and surface plasmon resonance sensing device and method
10/29/2009CA2721582A1 Recombinant deamidated gliadin antigen
10/29/2009CA2720876A1 Test system
10/29/2009CA2720682A1 Levels of bcma protein expression on b cells and use in diagnostic methods
10/29/2009CA2720465A1 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
10/29/2009CA2719385A1 Pancreatic beta-cell mass biomarker
10/29/2009CA2719078A1 Antiviral therapy
10/28/2009EP2112513A2 Chromatographic test device
10/28/2009EP2112512A2 Radiolabeling kit and binding assay
10/28/2009EP2112511A1 Method of screening candidate compounds for susceptibility to biliary excretion
10/28/2009EP2112510A1 Use of biological photo-receptors as direct light-controlled ion channels
10/28/2009EP2112509A1 Centrosome-assay
10/28/2009EP2112508A1 Aggregometer
10/28/2009EP2112503A2 Method and device for verifying the absence of foodstuff residues in moulds for foodstuffs, in particular chocolate products
10/28/2009EP2112501A1 Method and device for measuring luminescence
10/28/2009EP2112500A1 Plasmonic biosensor
10/28/2009EP2112234A2 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy
10/28/2009EP2112233A1 Pyrophosphorolysis activated polymerization (PAP): application to allele-specific amplification and nucleic acid sequence determination
10/28/2009EP2112232A1 Methods for extracting pathogen nucleic acid from a blood sample using aurintricarboxylic acid
10/28/2009EP2112231A2 MarA family helix-turn-helix domains and methods of use
10/28/2009EP2112229A2 Methods for identifying risk of breast cancer and treatments thereof
10/28/2009EP2112228A1 Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating effect of antimicrobial agent, and antimicrobial agent
10/28/2009EP2112222A1 Gene encoding guanine nucleotide exchange factor and gene product thereof
10/28/2009EP2112168A1 Use of thermostable biotin-binding protein and solid support having the protein bound thereto
10/28/2009EP2112166A2 Human monoclonal antibodies to CTLA-4
10/28/2009EP2112165A2 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
10/28/2009EP2112159A2 Immuno-interactive fragments of the alpha C subunit of inhibin
10/28/2009EP2112158A1 Detection of primary infections with pathogens
10/28/2009EP2112157A1 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
10/28/2009EP2111786A1 Test system
10/28/2009EP2111556A1 Diagnostic composition and its use in the determination of coagulation characteristics of a test liquid
1 ... 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 ... 3937